- Home
- MRSN vs CZFS Comparison
MRSN vs CZFS Comparison
Compare MRSN & CZFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- CZFS
- Stock Information
- Founded
- MRSN 2001
- CZFS 1984
- Country
- MRSN United States
- CZFS United States
- Employees
- MRSN N/A
- CZFS N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- CZFS Major Banks
- Sector
- MRSN Health Care
- CZFS Finance
- Exchange
- MRSN Nasdaq
- CZFS Nasdaq
- Market Cap
- MRSN 252.0M
- CZFS 270.6M
- IPO Year
- MRSN 2017
- CZFS N/A
- Fundamental
- Price
- MRSN $1.86
- CZFS $66.52
- Analyst Decision
- MRSN Buy
- CZFS Strong Buy
- Analyst Count
- MRSN 6
- CZFS 1
- Target Price
- MRSN $6.00
- CZFS N/A
- AVG Volume (30 Days)
- MRSN 1.1M
- CZFS 24.7K
- Earning Date
- MRSN 11-13-2024
- CZFS 01-28-2025
- Dividend Yield
- MRSN N/A
- CZFS 2.85%
- EPS Growth
- MRSN N/A
- CZFS 34.84
- EPS
- MRSN N/A
- CZFS 5.75
- Revenue
- MRSN $34,837,000.00
- CZFS $98,201,000.00
- Revenue This Year
- MRSN N/A
- CZFS N/A
- Revenue Next Year
- MRSN N/A
- CZFS $9.21
- P/E Ratio
- MRSN N/A
- CZFS $11.90
- Revenue Growth
- MRSN N/A
- CZFS 19.13
- 52 Week Low
- MRSN $1.22
- CZFS $38.52
- 52 Week High
- MRSN $6.28
- CZFS $75.40
- Technical
- Relative Strength Index (RSI)
- MRSN 42.16
- CZFS 48.26
- Support Level
- MRSN $1.93
- CZFS $68.19
- Resistance Level
- MRSN $2.81
- CZFS $71.14
- Average True Range (ATR)
- MRSN 0.24
- CZFS 2.21
- MACD
- MRSN -0.05
- CZFS -0.64
- Stochastic Oscillator
- MRSN 7.79
- CZFS 3.33
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management and retirement services.